Stemtech (STEK) EBITDA Margin (QoQ) (2021 - 2025)

Stemtech (STEK) EBITDA Margin (QoQ) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Stemtech - - 354,677.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -26,063.00
Sep 30, 2025 -7,067.00
Jun 30, 2025 14,484.00
Mar 31, 2025 -11,694.00
Dec 31, 2024 24,659.00
Sep 30, 2024 -17,052.00
Jun 30, 2024 12,015.00
Mar 31, 2024 -7,928.00
Dec 31, 2023 838.00
Sep 30, 2023 -7,409.00
Jun 30, 2023 17,514.00
Mar 31, 2023 -18,993.00
Dec 31, 2022 -163,323.00
Sep 30, 2022 355,036.00
Jun 30, 2022 -186,518.00
Mar 31, 2022 -1,600.00
Dec 31, 2021 59,295.00
Sep 30, 2021 -60,864.00
Jun 30, 2021 1,116.00